Verve Therapeutics
David is the associate director, pharmacokinetics and biodistribution at Verve. Prior to joining Verve, David was a project lead and modeler at Applied BioMath, where he supported client programs across multiple disease areas, modalities, and stages of drug development. During this time, he developed scientific strategies for over two dozen projects and led cross-departmental initiatives to strengthen scientific support for the business team. David received his Ph.D. in biomedical engineering from Cornell University.
This person is not in the org chart
This person is not in any teams
Verve Therapeutics
59 followers
Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.